Search results
-
Blog
How Improving Diversity Can Benefit Clinical Trials
Representation and inclusion of various minority groups is crucial for medical research. Discover how drug developers, researchers, and regulators are ensuring this happens.
-
Scientific Publication
Nanomilling from Screening to Scale-up
Altasciences determines the suitability of nano milling for a client’s highly active compound with very poor aqueous solubility and less than desirable bioavailability.
-
Scientific Publication
Altasciences Fills Need of Leading Cancer Therapeutic Drug Developer
A leading developer of novel cancer therapeutics was experiencing persistent manufacturing process issues. Our engineers were able to diagnose and solve two problems.
-
Blog
Case Study: Achieving a 505(b)(2) Regulatory Approval for Multiple NDA-Enabling Studies
See how Altasciences supported a sponsor’s 505(b)(2) submission with three pivotal studies, driving simulation, bioavailability, and dose-escalation, to deliver critical data.